Overview

Effect of Pharmacokinetics in Healthy Chinese Subjects

Status:
COMPLETED
Trial end date:
2023-10-31
Target enrollment:
Participant gender:
Summary
This study is a single-center, open label, self-controlled phase I clinical study, to evaluate the effects of clarithromycin or cyclosporine on pharmacokinetics of deuterium hydrobromide ramidvir tablets in healthy Chinese subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Shanghai Vinnerna Biosciences Co., Ltd.
Treatments:
Clarithromycin